How Is Somatic Symptom Disorder Diagnosed? DSM-5-TR Criteria and Assessment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Somatic Symptom & Functional Disorders · Written by Artificial Sapiens
Somatic symptom disorder (SSD) is diagnosed through a clinical assessment of persistent, distressing physical symptoms together with the person's thoughts, feelings, and behaviors in response to those symptoms. Under the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), clinicians evaluate three connected requirements: a significant physical symptom burden, at least one excessive symptom-related psychological or behavioral response, and persistence of the symptomatic state, usually for more than six months. A symptom does not have to be medically unexplained for SSD to be diagnosed. Physical symptoms deserve appropriate medical evaluation throughout the process. The American Psychiatric Association's patient guidance describes the same essential clinical principle.
The diagnosis requires a comprehensive medical and mental health assessment. Neither normal laboratory results nor a high health-anxiety or somatic-symptom questionnaire score can establish SSD on its own. An accurate assessment asks what a person experiences, what medical conditions may contribute, how daily life has changed, and whether the pattern of symptom-related distress and behavior meets the criteria within the person's actual medical and social circumstances.
What are the DSM-5-TR diagnostic criteria for somatic symptom disorder?
The DSM-5-TR retains the central three-part approach introduced in DSM-5. The following is a clinical explanation of Criteria A, B, and C rather than a substitute for the copyrighted diagnostic manual. The American Psychiatric Association and the published DSM criteria overview in Focus provide authoritative descriptions of the framework.
Criterion A: One or more significant somatic symptoms
There must be at least one physical symptom that causes meaningful distress or interferes substantially with daily activities. Somatic means bodily or physical. A clinician might hear about persistent pain, fatigue, digestive symptoms, dizziness, weakness, breathlessness, palpitations, or another symptom affecting the person's life. The diagnosis does not require a particular symptom, a minimum number of organ systems, or a checklist of several unexplained complaints.
The assessment establishes what the symptoms actually feel like, when they began, how frequently they occur, how severe they are, and what they prevent the person from doing. A person may have a single severe symptom or several symptoms of varying intensity. Symptoms may shift over time. A symptom's impact matters clinically, including missed work, interrupted sleep, restrictions on social life, or difficulty completing ordinary tasks.
Criterion A concerns the patient's lived physical experience and functional impact. It does not determine the biological explanation for that experience. Someone may have a recognized medical illness, a functional disorder, several interacting conditions, or an unresolved medical question. None of these possibilities is settled by the SSD label.
Criterion B: Excessive thoughts, feelings, or behaviors related to the symptoms
At least one of three patterns must be clinically significant: persistent and disproportionate beliefs about the seriousness of symptoms; persistently elevated anxiety about health or symptoms; or excessive amounts of time and energy devoted to symptom-related concerns. These are alternatives within the same criterion. All three are not required.
The word excessive must be assessed carefully. A person coping with serious illness, uncertain test results, prior medical neglect, disability, or a recent medical crisis may reasonably seek repeated evaluation or experience significant anxiety. The diagnostic question is whether the pattern is persistently disproportionate in its context, causes further impairment, and cannot be better understood simply as an appropriate response to the circumstances.
Examples of a possible Criterion B pattern include an enduring conviction that a familiar, repeatedly evaluated symptom must signal imminent catastrophe despite a coherent medical explanation and monitoring plan; extensive checking of bodily sensations that repeatedly disrupts everyday life; or persistent health-related preoccupation that consumes most of a person's attention. These examples only illustrate possible clinical observations. No single behavior automatically qualifies, and seeking medical care is never proof of a psychiatric disorder.
A clinician asks how these responses developed, how flexible they are when new evidence arrives, whether behaviors offer temporary reassurance but sustain preoccupation over time, and how the responses affect sleep, relationships, treatment decisions, and functioning. The person's own explanation, medical history, access to care, cultural beliefs, and past experiences of being disbelieved are indispensable to judging proportionality. Research has criticized the potential subjectivity and risk of over-inclusion in this criterion, including Rief and Martin's critical evaluation.
Criterion C: The symptomatic state is persistent
The overall pattern of being symptomatic is persistent, typically longer than six months. The same physical symptom does not have to occur every day, and an individual symptom may disappear while another becomes prominent. Clinicians assess the continuity of the symptomatic state across the clinical history rather than treating six months as a requirement for each separate sensation.
Duration is established through the patient's narrative and, when useful, medical records, symptom timelines, and previous evaluations. A presentation lasting only a few weeks does not automatically qualify as SSD. It may call for medical investigation, follow-up, and an assessment of anxiety or distress without prematurely assigning a persistent-disorder diagnosis. The DSM also provides other specified categories for certain shorter presentations; those are separate clinical decisions.
Does SSD require unexplained symptoms or normal test results?
No. Under DSM-5-TR, a known medical illness does not exclude somatic symptom disorder. A person with inflammatory disease, a neurological condition, cancer, chronic pain, or another diagnosed illness can also have SSD if all of the additional diagnostic criteria are met. Conversely, persistent symptoms that remain medically unexplained do not automatically establish SSD. The APA's official explanation explicitly addresses both points.
This distinction is fundamental to ethical diagnosis. The medical diagnosis answers questions about bodily disease processes, physiology, and appropriate clinical treatment. SSD assessment asks whether there is a qualifying, persistent pattern of distress and symptom-focused cognition or behavior. The two clinical questions may need to be evaluated together. A clinician must not use a psychiatric diagnosis to erase a physical illness or the possibility of discovering another one.
Pain and disability also complicate judgments about disproportionate responses. Extensive health-related activities can be medically necessary for people who monitor diabetes, manage seizures, attend dialysis, or cope with serious fluctuating illnesses. The relevant question is the individual's overall clinical pattern, including medical necessity, safety, available support, and degree of impairment. Discussions of potential overdiagnosis among patients with chronic pain show why this judgment deserves explicit clinical reasoning.
How does the diagnostic assessment work in practice?
An appropriate assessment is a staged process. Its order varies according to the presenting symptoms and care setting, but it usually combines a physical evaluation, a psychiatric or psychological interview, an appraisal of functional impact, and differential diagnosis. The Merck Manual professional guidance describes medical evaluation and psychiatric assessment as complementary components.
Step 1: Establish a clear history of the physical symptoms
The clinician identifies the chief symptoms, initial onset, course, locations, severity, variability, associated features, triggers, relieving factors, prior episodes, and treatments. A symptom timeline can clarify whether a new medical problem preceded the distress or whether the pattern followed illness, a procedure, a medication change, sleep disturbance, or another identifiable event. The patient should have an opportunity to describe the symptoms without a premature psychological explanation.
A full history includes existing diagnoses, medication and substance use, allergies, family history, past test results, hospital visits, and treatments that helped or harmed. The clinician considers the person's age, sex-related medical factors, pregnancy-related considerations when relevant, disability status, and available access to follow-up. Reviewing previous records can prevent duplication while exposing gaps that deserve attention.
Step 2: Perform an appropriate medical examination and targeted investigations
The clinical examination is directed by the symptoms and medical history. Depending on the presentation, this may include examination of neurological, cardiovascular, respiratory, gastrointestinal, musculoskeletal, or other systems. The decision to obtain blood tests, imaging, specialist consultation, or other investigations comes from the clinical differential diagnosis and recognized warning signs.
The goal is proportionate medical evaluation, with documentation of which possibilities have been considered and what would prompt reassessment. An SSD assessment does not depend on proving that every possible disease has been excluded, and a prior unrevealing evaluation does not settle the meaning of new symptoms. Repeating tests without a new indication can also have costs, false-positive consequences, and procedural harms. The balance requires a clinician who knows the case and communicates the plan clearly.
Sudden severe chest pain, symptoms suggestive of stroke, new severe shortness of breath, loss of consciousness, severe acute abdominal pain, rapidly progressive weakness, major bleeding, or another acute dangerous change needs urgent medical evaluation based on the presentation. Such symptoms should never be assigned to SSD through remote interpretation or an old diagnosis.
Step 3: Evaluate symptom-related thoughts, emotions, and behavior
The mental health interview explores fear of disease, perceived seriousness of symptoms, repetitive attention to bodily sensations, checking behavior, reassurance seeking, avoidance of activity, internet searching, treatment-related worries, and the amount of time devoted to health concerns. The interviewer also considers coping responses that may be helpful, such as symptom management routines recommended by clinicians, appropriate self-monitoring, and asking for necessary clarification.
The clinician asks about the context in which anxiety occurs. Fear while waiting for a biopsy result or concern after repeated misdiagnosis has a different clinical meaning from a stable pattern of catastrophic interpretation that remains disproportionate through a long, well-explained course. The discussion should identify what the patient believes, what uncertainty persists, what supports are available, and whether particular behaviors increase distress or impair functioning.
Step 4: Assess functioning and the broader psychological picture
The assessment considers sleep, work, education, caregiving, mobility, exercise tolerance, social connection, and the ability to follow necessary medical treatment. It also screens for depression, panic attacks, generalized anxiety, obsessive-compulsive symptoms, trauma-related symptoms, substance use, and other clinically relevant conditions when indicated. A psychological difficulty can coexist with physical disease without replacing its medical evaluation.
Functional impairment needs context. Missing work because of severe pain can reflect the pain itself; avoiding all activity because of a persistent, disproportionate belief that ordinary movement will cause catastrophic damage may involve a different process. Clinicians can document both, acknowledging that the causes of impairment are often multiple and that a single diagnosis may not account for the entire presentation.
Step 5: Make a careful differential diagnosis
The clinician compares the presentation with relevant medical and psychiatric possibilities before establishing a diagnosis. This is especially important if symptoms are new, worsening, atypical, or inconsistent with the proposed formulation. A useful assessment identifies which diagnoses remain possible, which evidence currently favors the leading explanation, and what follow-up would change the plan.
Step 6: Explain the assessment and agree on a continuing care plan
The clinician should explain which criteria are met, what medical findings have been identified, where uncertainty remains, and how the diagnosis informs care. A collaborative plan may involve a primary care clinician coordinating relevant specialty care and a mental health professional addressing the symptom-related distress or behaviors. Follow-up should include realistic goals for functioning, symptom management, and reassessment of medical changes. Communication that takes physical suffering seriously improves the conditions for effective care.
How do clinicians decide whether a response is 'excessive'?
There is no single objective laboratory marker or universally reliable numerical boundary for an excessive symptom-related response. Clinical judgment must consider the nature and severity of the illness, the prognosis and uncertainty communicated to the patient, necessary treatment tasks, financial and geographic access to care, past experiences of error, family obligations, disability accommodations, and relevant cultural expectations.
The clinician evaluates a persistent pattern rather than isolated moments. A frightened comment made during an emergency, a request for a second opinion after conflicting findings, or frequent monitoring specifically directed by a medical team cannot by itself demonstrate Criterion B. Clinicians should distinguish impairment due to symptoms from additional impairment related to preoccupation, fear, or responses to those symptoms.
A careful assessment can document concrete examples: time spent monitoring symptoms on a typical day, specific activities avoided, repeated contacts with services despite an agreed plan, changes in beliefs after appropriate explanations, or problems following necessary treatment because of persistent symptom fears. These observations require interpretation in the full clinical context and discussion with the patient. Rief and Martin describe important validity challenges with the diagnostic model. Those challenges support disciplined assessment rather than casual labeling.
Which diagnostic specifiers and severity ratings are used?
Clinicians may specify a presentation with predominant pain when pain is the principal somatic complaint. The DSM also recognizes a persistent course and current severity categories. In the published DSM-5 framework, mild severity involves one qualifying Criterion B manifestation; moderate severity involves two or more; severe severity involves two or more together with multiple somatic complaints or one particularly severe somatic symptom. The persistent specifier refers to substantial impairment and a long course. The wording and correct application belong to the formal clinical assessment, not to a self-assessment checklist. See the APA-published explanation of DSM changes.
These categorical specifiers summarize a diagnostic presentation. They are not a measure of whether the patient is honest, how much physical disease exists, or whether the symptoms merit medical care. Symptom severity, distress, functional limitations, and psychiatric diagnostic severity should be documented separately. Severe physical illness does not automatically mean severe SSD, and mild SSD does not imply mild physical suffering.
Can a questionnaire diagnose somatic symptom disorder?
Questionnaires help organize assessment, estimate symptom burden, and identify people who could benefit from further discussion. They are screening and monitoring instruments rather than standalone diagnostic tests. An interview and medical evaluation remain necessary.
PHQ-15 and SSS-8: Physical symptom burden
The Patient Health Questionnaire-15 (PHQ-15) and Somatic Symptom Scale-8 (SSS-8) ask about common bodily symptoms. They can help characterize severity and monitor change over time. They do not independently measure whether a person's beliefs or behaviors satisfy Criterion B.
A 2024 systematic review and meta-analysis published in JAMA Network Open included 305 studies and more than 361,000 participants. It supported use of these instruments for symptom-burden assessment while finding limitations in using them as diagnostic screens for somatoform disorders. Scores can also be elevated in many medical illnesses.
SSD-12: Responses to symptoms
The Somatic Symptom Disorder–B Criteria Scale (SSD-12) assesses forms of symptom-related preoccupation, health anxiety, and behavior connected to the DSM criterion. It can focus a clinical conversation, but a high score cannot distinguish all legitimate medical concerns from persistently disproportionate responses. Context and structured interview remain essential.
In an interview-based diagnostic accuracy study involving 372 psychosomatic outpatients, individual screening measures showed only moderate discrimination; selected combinations improved accuracy but still generated false positives and false negatives. A Dutch specialty-clinic validation study reported an area under the receiver operating curve of 0.75 for SSD-12 in a mixed clinical sample, with sensitivity and specificity dependent on the threshold and diagnostic comparison.
Why a published cutoff should not be treated as a diagnosis
Cutoff values are influenced by patient selection, medical comorbidity, differences in reference interviews, language, culture, and underlying prevalence. A threshold derived from a specialty clinic may perform differently in general primary care. A 2024 primary-care study examined whether previously proposed questionnaire combinations transferred to unselected patients and highlighted the importance of setting-specific validation.
A 2026 psychometric study evaluated PHQ-15 and SSD-12 instruments, including shorter one-week timeframes for repeated monitoring. It provided cautious support for some measurement properties, while identifying limitations including poor test–retest reliability in healthy volunteer data. Measurement research continues to refine how clinicians track symptoms and preoccupation; it has not supplied a laboratory-equivalent confirmation test for SSD.
The APA's clinician-rated severity instrument is described by the publisher as an emerging measure for assessment and monitoring, not a substitute for clinical diagnostic judgment. Instruments should be chosen and interpreted by appropriately trained professionals.
What conditions must be distinguished from SSD?
Several conditions can involve physical symptoms, health worry, or both. Some can coexist with SSD; the purpose of differential diagnosis is to establish what best explains each part of the clinical presentation and which problems need their own treatment.
Medical conditions and symptom disorders
Endocrine, cardiovascular, gastrointestinal, rheumatological, neurological, infectious, respiratory, sleep-related, medication-related, and other medical conditions can produce substantial bodily symptoms. Examples may include thyroid disease, anemia, autoimmune or inflammatory illness, obstructive sleep apnea, medication adverse effects, migraine, inflammatory bowel disease, cardiac conditions, and many others. The relevant differential depends on the person's specific clinical presentation, not on a standard list of tests ordered for everyone.
Fibromyalgia, irritable bowel syndrome, migraine, and persistent pain or fatigue syndromes have their own clinical presentations and care pathways. A diagnosis of one does not imply SSD. These conditions belong to appropriate medical, rehabilitation, and health-psychology care pathways, with an additional SSD assessment only when clinically warranted.
Illness anxiety disorder and broader health anxiety
Illness anxiety disorder usually centers on preoccupation with having or developing a serious illness while physical symptoms are absent or relatively mild. SSD requires one or more significantly distressing or disruptive physical symptoms plus the additional symptom-related response pattern. Severe concern about illness can occur in either disorder, and ordinary health anxiety is not itself a diagnosis.
The distinction depends on what is most prominent: the substantial bodily symptoms and responses to them, or the feared illness despite little physical symptom burden. The comparison may change as the clinical picture develops and requires a careful interview. Anxiety alone is insufficient to decide between these conditions.
Panic disorder, generalized anxiety, and depression
Panic attacks can produce palpitations, chest discomfort, shortness of breath, dizziness, and gastrointestinal distress. Generalized anxiety may involve muscle tension, fatigue, and worry across many domains. Depressive conditions may be accompanied by pain, reduced energy, impaired sleep, and changes in appetite. Clinicians examine onset, duration, episodes versus persistent patterns, and the defining psychological features of each condition.
Someone experiencing bodily sensations during a panic attack deserves appropriate medical assessment based on the symptoms and circumstances. The English Hub's existing guide to physical symptoms of anxiety discusses this distinct anxiety-focused question.
Obsessive-compulsive disorder and body-focused preoccupation
OCD may involve intrusive obsessions about contamination, illness, bodily processes, or feared consequences, together with compulsions such as checking, reassurance seeking, or mental rituals. Assessment focuses on the quality of intrusive thoughts and the function of compulsions rather than merely counting visits to medical websites. Existing English Hub coverage addresses OCD versus illness anxiety disorder, a separate diagnostic comparison.
Functional neurological disorder
Functional neurological disorder (FND) may cause weakness, altered movement, seizures, sensory symptoms, or other neurological presentations. Neurologists assess clinically relevant positive signs showing internal inconsistency or incongruity with recognized neurological disease patterns, supported by the appropriate examination. FND is not established solely because testing did not reveal structural pathology. FND and SSD are distinct diagnostic concepts and can sometimes coexist.
Trauma-related, dissociative, and psychotic conditions
Trauma-related disorders and dissociative experiences can influence attention, arousal, bodily sensations, and interpretation of symptoms, but trauma is not a required explanation for SSD. Specific psychiatric and neurological symptoms need their own assessment. Fixed delusional beliefs, when present, call for careful evaluation of possible psychotic disorders rather than simply being described as excessive health worry.
Factitious disorder and malingering
Factitious disorder involves intentional falsification or induction of symptoms in an identified clinical context. Malingering refers to intentional symptom fabrication or exaggeration motivated by external incentives and is treated differently in clinical classification. SSD is not established through deliberate deception. A patient's extensive medical history, complex illness behavior, conflicting reports, or the absence of a clear medical explanation does not justify an allegation of intentional fabrication. Such judgments require a fundamentally different level of evidence and appropriate professional evaluation.
How does DSM-5-TR SSD compare with ICD-11 bodily distress disorder?
International clinicians may use the World Health Organization's ICD-11 rather than the American Psychiatric Association's DSM-5-TR. ICD-11 includes bodily distress disorder (BDD), code 6C20, in the category of disorders of bodily distress or bodily experience. Its clinical requirements concern distressing bodily symptoms and excessive attention directed toward them, with persistence and impairment evaluated in the ICD-11 model. The WHO's 2024 Clinical Descriptions and Diagnostic Requirements is the authoritative reference.
The two frameworks overlap clinically but should not be treated as interchangeable codes or identical diagnostic algorithms. Differences in diagnostic wording, the organization of attention and response criteria, severity specifications, and classification context can matter. A clinician who records an ICD-11 diagnosis should apply ICD-11 requirements rather than assuming that every DSM-5-TR SSD assessment automatically yields the same label.
Neither framework licenses the assumption that bodily symptoms are fabricated. Both require appropriate consideration of the medical setting and the person's experience. Formal crosswalk questions belong to a separate classification comparison rather than a conversion rule based on a single questionnaire.
How is somatic symptom disorder evaluated in children and adolescents?
Children and teens may present with abdominal pain, headaches, fatigue, dizziness, or other substantial symptoms that affect attendance, peer relationships, family routines, and development. Assessment is adapted to age, developmental abilities, communication style, and available caregivers. A parent or teacher may describe impairment differently from the young person's own report, and clinicians should take the young person's direct experience seriously.
Appropriate pediatric evaluation considers physical illness, growth and development, medications, sleep, school pressures, bullying, family stressors, anxiety and mood, neurodevelopmental differences, and accommodations that could support functioning. Family involvement should be collaborative rather than organized around blaming caregivers or attributing all physical symptoms to stress.
The pediatric literature uses several partially overlapping diagnostic terms. A systematic review of adolescent somatic symptom disorders emphasized variation in terminology and limitations in age-specific research. A systematic review and meta-analysis of childhood somatoform symptoms and disorders similarly documented heterogeneous definitions. Accordingly, prevalence estimates from older somatoform categories should not simply be labeled prevalence of DSM-5-TR SSD.
School refusal, falling grades, or extensive absences may signal substantial impairment but do not independently prove SSD. Medical examination, functional assessment, supportive school planning, and careful communication among families and clinicians are part of responsible care.
What if the clinician suspects SSD while a medical condition is still being investigated?
The care plan should specify what is currently known, which medical concerns remain under investigation, what symptoms or findings require a change in evaluation, and how psychological distress can be addressed in parallel. Symptom-focused treatment and anxiety management can be clinically useful even when the final medical explanation is unsettled. A psychological referral does not require a declaration that further medical questions are closed.
An SSD diagnosis, if the criteria are otherwise met, should be documented transparently and revisited when new information arises. This principle applies especially to people who have experienced delayed recognition of rare illnesses, fragmented health systems, or significant access barriers. The diagnosis should enable coordinated care and accurate attention to both physical and psychological dimensions.
Three illustrative assessment scenarios
These examples describe how clinicians might reason about a presentation; none can establish a diagnosis without direct evaluation.
Scenario 1: Persistent pain with a recognized disease
A person with a diagnosed inflammatory condition has pain and fatigue for a year. Some medical monitoring, lifestyle adjustments, and specialist visits are justified by the illness. The person's concern about disease progression is understandable. A clinician considers SSD only if a separately identifiable, sustained, disproportionate pattern of symptom-related thoughts, feelings, or behaviors meets Criterion B, alongside the other criteria. Medical treatment continues in either case.
Scenario 2: Worry about cancer with few physical symptoms
A person has recurring fear of cancer, checks for signs every day, and seeks reassurance, but experiences little ongoing physical symptom burden. This presentation may raise questions about illness anxiety disorder or other anxiety-related conditions. It does not meet SSD merely because the health concern is intense. A clinician evaluates the full history and differential before assigning any label.
Scenario 3: Months of symptoms with unresolved medical findings
A person reports abdominal pain and intermittent dizziness, with limited initial findings and substantial difficulty functioning. The symptoms warrant proportionate medical evaluation and follow-up. The clinician may also assess whether worry, repetitive monitoring, and avoidance have become clinically impairing. Unexplained symptoms alone cannot provide the missing Criterion B judgment, and new alarm features still need evaluation.
What happens after a diagnosis?
The immediate clinical task is to build a shared formulation that recognizes bodily symptoms, identified medical illness, symptom-related distress, functional limitations, and any associated psychological conditions. The care team can then set measurable goals that matter to the patient: better sleep, steadier participation in work or school, reduced time lost to unhelpful checking, improved mobility within medical limits, and a safe plan for worsening symptoms.
A primary clinician can coordinate necessary medical care, organize regular follow-up, avoid duplicative investigations without indications, and reconsider the differential when the presentation changes. Cognitive behavioral therapy (CBT) may help selected patients address catastrophic interpretations, checking, avoidance, and restrictions in daily life. Appropriate treatment of coexisting depression, anxiety, pain, or medical conditions may also be important.
The treatment evidence needs careful interpretation. A Cochrane review of earlier somatoform disorders and medically unexplained symptoms found modest average benefits for psychological therapies compared with usual care, with heterogeneous and low-to-moderate-quality evidence. Much of this evidence predates DSM-5-TR SSD and cannot automatically be applied to every person meeting its newer criteria. A 2018 review of functional somatic syndromes and bodily distress supports coordinated, stepped care but addresses overlapping diagnostic populations, not an identical SSD case definition.
Medication choices should target identified indications, such as coexisting depression, anxiety, or another medical condition, after individualized assessment. There is no medication or psychological exercise that verifies SSD diagnostically. The presence of a mental health treatment plan never removes the need for appropriate medical reevaluation when symptoms change.
How can patients prepare for an assessment?
It can help to bring a concise symptom timeline, medication list, prior medical diagnoses, relevant test results, and a record of how symptoms affect work, school, sleep, mobility, and relationships. Tell the clinician what has changed, which concerns remain unanswered, what explanations have been offered, and which interventions have helped or worsened the situation.
Useful questions include: Which DSM-5-TR criteria do you believe are met, and on what clinical evidence? Which medical diagnoses are established or still possible? What findings would prompt more testing or a specialist referral? How will we manage current symptoms and functioning? Who is coordinating follow-up, and how can I raise a new symptom? Patients can request a clear explanation or an appropriate second opinion when important uncertainties remain.
Limitations and evidence gaps in SSD diagnosis
The core DSM-5-TR diagnostic framework is established as a professional classification system. Reliability and validity of individual clinical judgments, especially the assessment of disproportionate symptom-related responses across different illnesses and cultures, remain subjects of empirical debate. Classification status should be distinguished from proof of a single underlying biological cause.
Research on questionnaires is substantial but cannot replace a clinician's differential assessment. Specialty-clinic samples can overestimate the performance of cutoffs in general primary care. Older research frequently combines populations labeled somatoform disorder, somatization, persistent physical symptoms, or medically unexplained symptoms. These terms do not identify exactly the same population as DSM-5-TR SSD. Cross-study treatment and prevalence claims therefore require diagnostic attention.
The 2024 JAMA Network Open synthesis supports measurement of symptoms more strongly than diagnosis from scores. The 2026 PHQ-15 and SSD-12 study contributes evidence about repeated measurement but cannot establish diagnostic accuracy across all care settings. Pediatric classification evidence remains heterogeneous. No imaging test, blood test, gene, or physiological biomarker has been validated to diagnose SSD in an individual.
Frequently asked questions about somatic symptom disorder diagnosis
What is the main requirement for an SSD diagnosis?
The patient must have distressing or disruptive physical symptoms, at least one qualifying pattern of excessive symptom-related thoughts, feelings, or behaviors, and a persistent symptomatic state usually lasting more than six months. The requirements are assessed clinically and together.
Can SSD be diagnosed if my MRI and blood tests are normal?
Normal findings alone are insufficient. They may help answer specific medical questions, but SSD additionally requires the positive clinical information described in the DSM-5-TR model. Appropriate medical assessment remains necessary.
Can someone have SSD and an autoimmune disease or another medical diagnosis?
Yes. Medical illness and SSD may coexist if the full SSD criteria are independently met. Their coexistence does not invalidate the physical disease or justify withholding treatment for it.
How long do symptoms have to last?
Criterion C concerns a persistent state of bodily symptoms, typically longer than six months. Individual symptoms may come and go or change in type. Duration is assessed from the complete clinical history.
How many symptoms are needed?
One sufficiently distressing or disruptive physical symptom can fulfill Criterion A. Multiple symptoms are not required, and a longer symptom list does not by itself establish SSD.
Does SSD mean that symptoms are imagined?
No. The diagnosis concerns real bodily experiences and the associated persistent pattern of symptom-related distress or responses. It does not imply deliberate symptom production or universal psychological causation.
Is SSD the same as hypochondria or health anxiety?
No. Historical hypochondriasis terminology was reorganized in modern classification. Illness anxiety disorder and SSD differ especially in the degree of physical symptom burden. Everyday health anxiety also does not automatically qualify as a psychiatric diagnosis.
Is somatic symptom disorder diagnosed by a psychiatrist only?
A qualified clinician with appropriate diagnostic competence must undertake the relevant assessment, often with coordination among primary care, mental health, and medical specialists. Local professional scope-of-practice rules differ. The essential requirement is an adequate medical and psychiatric evaluation rather than a particular online test or clinic label.
Is there a definitive SSD test?
No. PHQ-15, SSS-8, SSD-12, and clinician ratings can assist symptom assessment or monitoring, but none independently confirms or excludes SSD.
Can an SSD diagnosis be reconsidered?
Yes. A diagnosis is subject to clinical reassessment when significant new symptoms, medical findings, or changes in the mental health presentation arise. Continuing care should contain a mechanism for that reassessment.
Does everyone with persistent pain have SSD?
No. Persistent pain requires diagnosis and management in its own right. Only a subset of patients may additionally meet all SSD criteria. The assessment must distinguish justified illness management from independently excessive symptom-related responses.
Is functional neurological disorder another name for SSD?
No. FND has its own neurological diagnostic approach, often involving positive clinical examination signs. Both conditions may coexist, but neither label automatically establishes the other.
Do traumatic experiences have to be present?
No. Trauma may be relevant to an individual history, but it is not a required DSM-5-TR criterion for SSD and should not be inferred from symptoms.
Should someone with SSD stop seeing medical doctors?
No. Appropriate medical care continues, ideally with coordinated follow-up, targeted investigation when indicated, and clear plans for new or changing symptoms.
Can children or teenagers receive an SSD diagnosis?
They can be evaluated for relevant disorders when clinically indicated. The assessment must be developmentally appropriate, include suitable pediatric medical evaluation, and consider family and school functioning.
Does improvement with CBT prove the diagnosis?
No. CBT can help with distress, coping, and functioning across many medical and psychological conditions. Response to treatment is not a specific diagnostic marker of SSD.
Related Articles
For distinct discussions of overlapping symptoms and diagnoses, read Physical Symptoms of Anxiety: Heart, Breathing, Stomach, Muscles, and Dizziness, Anxiety and Interoception: Why Body Sensations Can Become Threat Signals, and OCD vs Illness Anxiety Disorder: Health Fears, Checking, Reassurance, and Obsessions. These existing pages address their own established search intents and do not replace a dedicated DSM-5-TR SSD diagnostic assessment.
References
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing. Official DSM-5-TR information.
American Psychiatric Association. (2022). Clinician-Rated Severity of Somatic Symptom Disorder (DSM-5-TR emerging measure). Official instrument.
American Psychiatric Association. (n.d.). What Is Somatic Symptom Disorder? Official patient and family guide.
American Psychological Association. (2023). Somatic symptom disorder. APA Dictionary of Psychology. Definition.
Dimsdale, J. E., Creed, F., Escobar, J., Sharpe, M., Wulsin, L., Barsky, A., Lee, S., Irwin, M. R., & Levenson, J. (2013). Somatic symptom disorder: An important change in DSM. Journal of Psychosomatic Research, 75, 223–228. DOI: 10.1016/j.jpsychores.2013.06.033.
Henningsen, P., Zipfel, S., Sattel, H., & Creed, F. (2018). Management of functional somatic syndromes and bodily distress. Psychotherapy and Psychosomatics, 87, 12–31. DOI: 10.1159/000484413.
Hybelius, J., Kosic, A., Salomonsson, S., et al. (2024). Measurement properties of the Patient Health Questionnaire–15 and Somatic Symptom Scale–8: A systematic review and meta-analysis. JAMA Network Open, 7(11), e2446603. DOI: 10.1001/jamanetworkopen.2024.46603.
Hybelius, J., et al. (2026). Measurement properties of the Patient Health Questionnaire 15 (PHQ-15) and Somatic Symptom Disorder B-criteria scale (SSD-12), including revised 1-week versions. Scientific Reports. DOI: 10.1038/s41598-026-50290-y.
Kleinstäuber, M., et al. (2014). Pharmacological interventions for somatoform disorders in adults. Cochrane Database of Systematic Reviews, CD010628. DOI: 10.1002/14651858.CD010628.pub2.
Rief, W., & Martin, A. (2014). How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: A critical evaluation and a proposal for modifications. Annual Review of Clinical Psychology, 10, 339–367. DOI: 10.1146/annurev-clinpsy-032813-153745.
Toussaint, A., et al. (2019). Detecting DSM-5 somatic symptom disorder: Criterion validity of the PHQ-15 and SSS-8 in combination with SSD-12. Psychological Medicine. PubMed.
van Dessel, N., et al. (2014). Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database of Systematic Reviews, CD011142. DOI: 10.1002/14651858.CD011142.pub2.
Vesterling, C., et al. (2023). Epidemiology of somatoform symptoms and disorders in childhood and adolescence: A systematic review and meta-analysis. Health & Social Care in the Community, 2023, 6242678. DOI: 10.1155/2023/6242678.
World Health Organization. (2024). Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders. Official publication.